Ep. 248 - Grand Rounds Preview: Eyes on the Target

Grand Rounds is an R&D meeting that represents BioCentury’s latest initiative to create new networks linking academic discoveries with translational skills and the investors who will finance them, BioCentury co-founder, President and CEO David Flores said on a special edition of the BioCentury This Week podcast previewing the new conference. The meeting, on Sept. 9-11 in Nashville, focuses on whether biotech can write a more successful playbook for translating from target to product.The podcast features three special guests who will be at the conference: McKinsey's Guang Yang, Candel Therapeutics' Paul Peter Tak, and Abby Trotter of Life Science Tennessee. There is still time to register for BioCentury Grand Rounds, which will take place Sept. 9-11 in Nashville. Network, partner and debate key bottlenecks in translation. See the conference website for more information.View full story: https://www.biocentury.com/article/65332400:00 - Introduction00:13 - Spotlight Grand Rounds02:03 - Conference Themes08:40 - Nashville's Biotech Ecosystem16:58 - Paul Peter Tak on I&I25:22 - McKinsey Report PreviewHave a question? Send us a text!